DRAGON PHARMA (153 Offers)
Product Information
Dragon PharmaCompound Details
Active Substance Vesugen (KED) Lyophilized bioregulatory tripeptide (Lys-Glu-Asp)
20 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life No published human PK data
Detection Limited data
Primary Mechanism Endothelial Gene-Expression Modulation
Cellular / Regenerative Impact Low
Product Information
Dragon PharmaCompound Details
Active Substance Vilon (Lys-Glu) Lyophilized bioregulatory dipeptide (Lys-Glu)
20 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life No published human PK data
Detection Limited data
Primary Mechanism Thymic Gene-Expression Modulation
Cellular / Regenerative Impact Low
Product Information
Dragon PharmaCompound Details
Active Substance Vasoactive Intestinal Peptide (VIP) Lyophilized neuropeptide (28 aa)
6 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 1–2 Minutes (IV)
Detection Limited data
Primary Mechanism VPAC1/VPAC2 Receptor Agonism
Vasodilatory / Immunomodulatory Impact Moderate
Product Information
Dragon PharmaCompound Details
Active Substance ARA-290 (Cibinetide) Lyophilized EPO-derived innate repair receptor agonist (11 aa)
16 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life No published human PK data
Detection Limited data
Primary Mechanism Innate Repair Receptor (EPOR/CD131) Agonism
Tissue Repair / Neuroprotective Impact Moderate
Product Information
Dragon PharmaCompound Details
Active Substance Cartalax (AED) Lyophilized bioregulatory tripeptide (Ala-Glu-Asp)
20 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life No published human PK data
Detection Limited data
Primary Mechanism Connective-Tissue Gene-Expression Modulation
Cellular / Regenerative Impact Low
Product Information
Dragon PharmaCompound Details
Active Substance Melanotan I (Afamelanotide) Lyophilized synthetic α-MSH analogue (13 aa)
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 30 Minutes
Detection Limited data
Primary Mechanism MC1R Agonism / Melanin Stimulation
Pigmentation / Tanning Effect High
Product Information
Dragon PharmaCompound Details
Active Substance Humanin Lyophilized mitochondrial-derived peptide (24 aa)
10 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life No published human PK data
Detection Limited data
Primary Mechanism gp130/WSX-1 Receptor Signalling / BAX Sequestration
Cytoprotective / Neuroprotective Impact Low
Product Information
Dragon PharmaCompound Details
Active Substance Testolone (RAD-140) Oral nonsteroidal selective androgen receptor modulator (SARM)
10 mg per tablet
Form Oral Tablets
Packaging 100 Tablets
Estimated Half-Life Approximately 24–36 Hours
Detection Up to 30–40 Days
HPTA Suppression High
Aromatization None
Product Information
Dragon PharmaCompound Details
Active Substance Stanozolol Oral anabolic-androgenic steroid (17α-alkylated)
2.5 mg per tablet
Form Oral Tablets
Packaging 100 Tablets
Estimated Half-Life Approximately 9 Hours
Detection Up to 5–6 Weeks
Liver Toxicity High
Water Retention Low
